January 15, 2021 22:20 | About us
Language: Tiếng Việt | ພາ​ສາ​ລາວ | ខ្មែរ | русский | 中文
A landmark partnership announced for development of COVID-19 vaccine in the UK

A landmark partnership announced for development of COVID-19 vaccine in the UK

18:29 | 06/05/2020

The University of Oxford has announced an agreement with the UK-based global biopharmaceutical company AstraZeneca, headquarter in the UK and representative office in Vietnam, for the further development, large-scale manufacture and potential distribution of the COVID-19, ChAdOx1 nCoV-19 vaccine candidate currently being trialled by the University. 

    Prev         Next